| Drug Name | ( TYKERB (LAPATINIB |
|---|---|
| المجموعة الدوائية |
Anticancer
|
| نوع وسيلة تقليل المخاطر |
رسالة موجهه للممارسين الصحيين
|
| Specialty (Theraputic area) |
Oncology
|
| المخاطر |
Comparative data have shown that Lapatinib based regimens are less effective than trastuzumab based regimens in certain settings |
| رسالة موجهه للممارسين الصحيين |
|